ENDORESIST PROJECT
——————————
Improving our understanding of the underlying mechanism behind endocrine resistance and to identify biomarkers for an individualized approach to cancer therapy.
ORGANOTYPIC MODEL
——————————
Organotypic model for breast cancer therapy prediction. We have successfully established our unselected ex vivo 3D cell culture (WTC) model.
STOCKHOLM HER2 PROJECT
——————————
The human epidermal growth factor receptor 2 (HER2) is overexpressed or gene amplified in about 15 % of breast cancers and is associated with aggressive tumors
IMAGE ANALYSIS
——————————
We use established image analysis softwares to improve biomarker assessment in routine pathology. We also develop in-house deep-learning based models for next generation image analysis together with the Rantalainen lab.
Dr. Johan Hartman
OUR TEAM
Professor Johan Hartman is group leader at Department of Oncology and Pathology, Karolinska Institutet. Senior consultant pathologist at Karolinska University Hospital.
Research focus on precision pathology; image analysis (computational pathology), molecular cancer profiling and patient-derived cancer models to predict patient-specific drug response.
Research focus on precision pathology; image analysis (computational pathology), molecular cancer profiling and patient-derived cancer models to predict patient-specific drug response.
